Washington University School of Medicine (Siteman Cancer Center) — St Louis, Missouri

Washington University School of Medicine (Siteman Cancer Center) is a clinical research site located in St Louis, Missouri, United States 63108.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Washington University School of Medicine (Siteman Cancer Center) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Small Cell Lung Cancer (SCLC), Large Cell Neuroendocrine Cancer (LCNEC), Neuroendocrine Prostate Cancer (NEPC).

Sponsors: Phanes Therapeutics.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Washington University School of Medicine (Siteman Cancer Center)?

Washington University School of Medicine (Siteman Cancer Center) has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Washington University School of Medicine (Siteman Cancer Center) conducted?

Washington University School of Medicine (Siteman Cancer Center) has 1 clinical trials on record, with 1 currently active. Their work covers Small Cell Lung Cancer (SCLC), Large Cell Neuroendocrine Cancer (LCNEC), Neuroendocrine Prostate Cancer (NEPC).

Is Washington University School of Medicine (Siteman Cancer Center) accredited by Crixeo Health?

Washington University School of Medicine (Siteman Cancer Center) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Washington University School of Medicine (Siteman Cancer Center)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.